CYCLOPHOSPHAMIDE, ETOPOSIDE, AND INFUSION CISPLATIN IN REFRACTORY SMALL-CELL LUNG-CANCER - A PRELIMINARY-REPORT

被引：7

作者：

FRYTAK, S

EAGAN, RT

RICHARDSON, RL

CREAGAN, ET

JETT, JL

COLES, DT

LEE, RE

机构：

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1987年 / 10卷 / 01期

关键词：

D O I：

10.1097/00000421-198702000-00007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 35

页数：3

共 14 条

[1]

EAGAN RT, 1981, CANCER TREAT REP, V65, P453

[2]

EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO

[3]

2-4

[4] VP-16 AND CISPLATIN AS 1ST-LINE THERAPY FOR SMALL-CELL LUNG-CANCER [J].

EVANS, WK ;

SHEPHERD, FA ;

FELD, R ;

OSOBA, D ;

DANG, P ;

DEBOER, G .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1471-1477

[5]

GOLDIE JH, 1982, CANCER TREAT REP, V66, P439

[6]

LOPEZ JA, 1982, P AM SOC CLIN ONCOL, V23, pC586

[7]

OSOBA D, 1981, P AM ASSOC CANC RES, V22, P495

[8]

PORTER LL, 1985, CANCER TREAT REP, V69, P479

[9]

POSNER MR, 1985, P AM SOC CLIN ONCOL, V4, P38

[10]

RICHARDSON RL, 1985, P AN M AM SOC CLIN, V4, P105

← 1 2 →